Literature DB >> 1751497

Phospholipase A2 engineering. X-ray structural and functional evidence for the interaction of lysine-56 with substrates.

J P Noel1, C A Bingman, T L Deng, C M Dupureur, K J Hamilton, R T Jiang, J G Kwak, C Sekharudu, M Sundaralingam, M D Tsai.   

Abstract

Site-directed mutagenesis studies of bovine pancreatic phospholipase A2 (PLA2, overproduced in Escherichia coli) showed that replacement of surface residue Lys-56 by a neutral or hydrophobic amino acid residue resulted in an unexpected and significant change in the function of the enzyme. The kcat for phosphatidylcholine micelles increases 3-4-fold for K56M, K56I, and K56F and ca. 2-fold for K56N and K56T but does not change for K56R. These results suggest that the side chain of residue 56 has significant influence on the activity of PLA2. In order to probe the structural basis for the enhanced activity, the crystal structures of wild-type and K56M PLA2 were determined by X-ray crystallography to a resolution of 1.8 A. The results suggest that the mutation has not only perturbed the conformation of the side chain of Met-56 locally but also caused conformational changes in the neighboring loop (residues 60-70), resulting in the formation of a hydrophobic pocket by residues Met-56, Tyr-52, and Tyr-69. Docking of a phosphatidylcholine inhibitor analogue into the active site of K56M, according to the structure of the complex of cobra venom PLA2-phosphatidylethanolamine inhibitor analogue [White, S.P., Scott, D. L., Otwinowski, Z., Gleb, M. H., & Sigler, P. (1990) Science 250, 1560-1563], showed that the choline moiety [N(CH3)3]+ is readily accommodated into the newly formed hydrophobic pocket with a high degree of surface complementarity. This suggests a possible interaction between residue 56 and the head group of the phospholipid, explaining the enhanced activities observed when the positively charged Lys-56 is substituted by apolar residues, viz., K56M, K56I, and K56F. Further support for this interpretation comes from the 5-fold enhancement in kcat for the mutant K56E with a negatively charged side chain, where there would be an attractive electrostatic interaction between the side chain of Glu-56 and the positively charged choline moiety. Our results also refute a recent report [Tomasselli, A. G., Hui, J., Fisher, J., Zürcher-Neely, H., Reardon, I.M., Oriaku, E., Kézdy, F.J., & Heinrikson, R.L. (1989) J. Biol. Chem. 264, 10041-10047] that substrate-level acylation of Lys-56 is an obligatory step in the catalysis by PLA2.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1751497     DOI: 10.1021/bi00115a010

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  12 in total

1.  Characterization of Ad5 E3-14.7K, an adenoviral inhibitor of apoptosis: structure, oligomeric state, and metal binding.

Authors:  Hee-Jung Kim; Mark P Foster
Journal:  Protein Sci       Date:  2002-05       Impact factor: 6.725

2.  Atomic resolution structure of the double mutant (K53,56M) of bovine pancreatic phospholipase A2.

Authors:  K Sekar; M Yogavel; D Gayathri; D Velmurugan; R Krishna; M-J Poi; Z Dauter; M Dauter; M-D Tsai
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-12-16

3.  cDNA sequence analysis and mutagenesis studies on the A chain of beta-bungarotoxin from Taiwan banded krait.

Authors:  L S Chang; P F Wu; C C Chang
Journal:  J Protein Chem       Date:  1996-11

4.  Purification, characterization, and molecular cloning of group I phospholipases A2 from the gills of the red sea bream, Pagrus major.

Authors:  N Iijima; S Uchiyama; Y Fujikawa; M Esaka
Journal:  Lipids       Date:  2000-12       Impact factor: 1.880

5.  Solution structure of porcine pancreatic phospholipase A2 complexed with micelles and a competitive inhibitor.

Authors:  B van den Berg; M Tessari; R Boelens; R Dijkman; R Kaptein; G H de Haas; H M Verheij
Journal:  J Biomol NMR       Date:  1995-02       Impact factor: 2.835

6.  Interaction of plant lipids with 14 kDa phospholipase A2 enzymes.

Authors:  B S Vishwanath; W Eichenberger; F J Frey; B M Frey
Journal:  Biochem J       Date:  1996-11-15       Impact factor: 3.857

7.  Design of new secreted phospholipase A2 inhibitors based on docking calculations by modifying the pharmacophore segments of the FPL67047XX inhibitor.

Authors:  Varnavas D Mouchlis; Thomas M Mavromoustakos; George Kokotos
Journal:  J Comput Aided Mol Des       Date:  2010-02-04       Impact factor: 3.686

8.  Structure and function of the catalytic site mutant Asp 99 Asn of phospholipase A2: absence of the conserved structural water.

Authors:  A Kumar; C Sekharudu; B Ramakrishnan; C M Dupureur; H Zhu; M D Tsai; M Sundaralingam
Journal:  Protein Sci       Date:  1994-11       Impact factor: 6.725

9.  Chemical modification and inactivation of phospholipases A2 by a manoalide analogue.

Authors:  S Fujii; Y Tahara; M Toyomoto; S Hada; H Nishimura; S Inoue; K Ikeda; Y Inagaki; S Katsumura; Y Samejima
Journal:  Biochem J       Date:  1995-05-15       Impact factor: 3.857

10.  Crystal structure of the Y52F/Y73F double mutant of phospholipase A2: increased hydrophobic interactions of the phenyl groups compensate for the disrupted hydrogen bonds of the tyrosines.

Authors:  C Sekharudu; B Ramakrishnan; B Huang; R T Jiang; C M Dupureur; M D Tsai; M Sundaralingam
Journal:  Protein Sci       Date:  1992-12       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.